Botanix Pharmaceuticals Limited (ASX:BOT)

Botanix Pharmaceuticals Revenue

Botanix Pharmaceuticals had revenue of 16.51M AUD in the half year ending December 31, 2025, with 4,267.43% growth. This brings the company's revenue in the last twelve months to 21.92M, up 959.25% year-over-year. In the fiscal year ending June 30, 2025, Botanix Pharmaceuticals had annual revenue of 5.79M with 179.74% growth.

• Revenue (ttm): 21.92M
• Revenue Growth: +959.25%
• P/S Ratio: 5.57
• Revenue / Employee: 1.99M
• Employees: 11
• Market Cap: 122.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.79M	3.72M	179.74%
Jun 30, 2024	2.07M	-1.70M	-45.14%
Jun 30, 2023	3.77M	1.02M	36.94%
Jun 30, 2022	2.75M	-4.13M	-60.00%
Jun 30, 2021	6.89M	-686.66K	-9.07%